Goebel, Sebastian; Prochaska, Juergen H.; Troebs, Sven-Oliver et al.
Rationale, design and baseline characteristics of the MyoVasc study: A prospective cohort study investigating development and progression of heart failureEUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY. 2020
Valerio, L; Ambaglio, C; Barone, M et al.
Recurrence Risk after First Symptomatic Distal versus Proximal Deep Vein Thrombosis According to Baseline Risk Factors.TH Open. Bd. 3. H. 1. 2020 S. e58-e63
Krueger, Irena; Gremer, Lothar; Mangels, Lena et al.
Reelin Amplifies Glycoprotein VI Activation and AlphaIIb Beta3 Integrin Outside-In Signaling via PLC Gamma 2 and Rho GTPasesARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. Bd. 40. H. 10. 2020 S. 2391-2403
van Paridon, Pauline C. S.; Panova-Noeva, Marina; van Oerle, Rene et al.
Relation between Tissue Factor Pathway Inhibitor Activity and Cardiovascular Risk Factors and Diseases in a Large Population SampleTHROMBOSIS AND HAEMOSTASIS. 2020
Barco, Stefano; Munger, Mario; Sebastian, Tim et al.
Reperfusion treatment for high-risk pulmonary embolism associated with COVID-19VASA-EUROPEAN JOURNAL OF VASCULAR MEDICINE. Bd. 49. H. 4. 2020 S. 257-258
Krieg, Valentin J.; Hobohm, Lukas; Liebetrau, Christoph et al.
Risk factors for chronic thromboembolic pulmonary hypertension - Importance of thyroid disease and functionTHROMBOSIS RESEARCH. Bd. 185. 2020 S. 20-26
Valerio, Luca; Barco, Stefano
Risk stratification of normotensive pulmonary embolism: One more ride on the merry-go-roundEUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE. Bd. 9. H. 4. 2020 S. 256-258
Bonaca, Marc P.; Bauersachs, Rupert M.; Anand, Sonia S. et al.
Rivaroxaban in Peripheral Artery Disease after RevascularizationNEW ENGLAND JOURNAL OF MEDICINE. Bd. 382. H. 21. 2020 S. 1994-2004
Goebel, Sebastian; Schwuchow-Thonke, Soeren; Jansen, Thomas et al.
Safety of transradial and transfemoral left ventricular compared with transfemoral right ventricular endomyocardial biopsyESC HEART FAILURE. 2020
Huang, Jessie; Hume, Adam J.; Abo, Kristine M. et al.
SARS-CoV-2 Infection of Pluripotent Stem Cell-Derived Human Lung Alveolar Type 2 Cells Elicits a Rapid Epithelial-Intrinsic Inflammatory ResponseCELL STEM CELL. Bd. 27. H. 6. 2020 S. 962-+